Mapping kids’ eye health data a priority
Funding provided to map children’s eye health data to improve kids’ eyecare in Aotearoa
Susanne Bradley3 min read
Advertisement
Funding provided to map children’s eye health data to improve kids’ eyecare in Aotearoa
US researchers found higher long-term variability and mean levels of blood pressure (BP) were associated with faster visual field (VF) progression in patients with glaucoma. Published in JAMA
US researchers have recommended clinicians monitor orthokeratology (ortho-k) patients' refraction, tomography, pachymetry and corneal biomechanics until stability is achieved before considering refrac
Apellis Pharmaceuticals announced Australia’s Therapeutic Goods Administration (TGA) has approved Syfovre (pegcetacoplan intravitreal injection) for the every-other-month treatment of adults with geog
Ashvattha Therapeutics has secured additional financing up to US$50 million (NZ$88.4m) for its at-home monthly subcutaneously-administered treatment for neovascular age-related macular degeneration (n
All you need to know about the CCLS NZ 2025 conference and workshop in Christchurch on 14-15 March
Shining a spotlight on glaucoma this month, Glaucoma New Zealand (GNZ) is sharing patient stories explaining their experiences of the disease and is inviting the country’s optometrists and ophthalmologists to help them share the message and keep referring patients.
Alcon has acquired Melbourne-based Cylite, known for its hyperparallel optical coherence tomography (HP-OCT) technology. “We are excited about the potential of this technology in whole-eye OCT imagi
US researchers have found a possible link between weight-loss drugs and ophthalmic complications
Glaukos has announced positive clinical updates for its iDose sustained release procedural pharmaceutical platform. The tech company’s 36-month follow-up analysis of its two phase 3 iDoseTR (travopr
NZ’s Commerce Commission responds after investigating RANZCO letter re: training optoms to provide laser treatments
Retinal imaging could help doctors diagnose and track how ‘long-Covid’ impacts people over time and provide insight into its causes, according to the authors of US study. Researchers used advan